Turner Christopher Durant

Chief Medical OfficerNuvalent, Inc. (NUVL) · full profile →Form 4 · filed Jul 15, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
4 non-derivative · 7 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 15, 2026Tender(U)32K$124.00$3.9M0
Jul 15, 2026Disposed to issuer(D)41K0
Jul 15, 2026Grant(A)14K$014K
Jul 15, 2026Disposed to issuer(D)14K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 15, 2026Disposed to issuer(D)303K0
Jul 15, 2026Disposed to issuer(D)3K0
Jul 15, 2026Disposed to issuer(D)107K0
Jul 15, 2026Disposed to issuer(D)144K0
Jul 15, 2026Disposed to issuer(D)48K0
Jul 15, 2026Disposed to issuer(D)38K0
Jul 15, 2026Disposed to issuer(D)18K0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-305073) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.